Christophe Rochais

Professor at the Faculty of Pharmaceutical Sciences at the University of Caen Normandy, he was appointed in January 2022, director of the Normandy Center for Studies and Research on Medicines. Within this research center, he leads a research group aimed at developing therapeutic and diagnostic tools in different therapeutic areas, particularly neurodegenerative diseases. These activities have, among other things, enabled the discovery of preclinical candidates for the treatment of these pathologies.